SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.

Han, Xiaoxu; Li, Jinming; Chen, Yu; Li, Yan; Xu, Yingchun; Ying, Binwu; Shang, Hong

Han, Xiaoxu; Li, Jinming; Chen, Yu; Li, Yan; Xu, Yingchun; Ying, Binwu; Shang, Hong.

Han X; National Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
Li J; National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital, National Center of Gerontology, Beijing, China.
Chen Y; Department of Clinical Laboratory, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Li Y; Department of Clinical Laboratory, People's Hospital of Wuhan University, Wuhan, China.
Xu Y; Department of Clinical Laboratory, Peking Union Medical College Hospital, Beijing, China.
Ying B; Department of Clinical Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Shang H; National Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China. Electronic address: hongshang100@hotmail.com.

Lancet ; 399(10336): 1690-1691, 2022 04 30.

Article in English | MEDLINE | ID: covidwho-1778514

Subject(s)

COVID-19; Nucleic Acids; China/epidemiology; Humans; Nucleic Acid Amplification Techniques; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nucleic Acids / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Lancet Year: 2022 Document Type: Article Affiliation country: S0140-6736(22)00577-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google